Showing results (731-740 of 1,011) with videos related to

Sort By:
Pageof 102
Diabetes Care|August 15, 2012
Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE studyJamie Morton, Sophia Zoungas, Qiang Li, et al.
Diabetologia|January 9, 2018
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialSigrid C van Steen, Mark Woodward, John Chalmers, et al.
Plos One|February 10, 2016
Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 StudyDanni Zheng, Hisatomi Arima, Shoichiro Sato, et al.
Diabetes, Obesity & Metabolism|March 10, 2026
Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE StudyRuirui Wang, Yonghong Zhang, Yijie Gao, et al.
European Heart Journal|March 14, 2009
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE studyXin Du, Toshiharu Ninomiya, Bastiaan de Galan, et al.
Plos One|April 28, 2017
Examination of an eHealth literacy scale and a health literacy scale in a population with moderate to high cardiovascular risk: Rasch analysesSarah S Richtering, Rebecca Morris, Sze-Ee Soh, et al.
The Lancet. Oncology|April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysisEmma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Hypertension (Dallas, Tex. : 1979)|July 14, 2010
Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trialsKaty J L Bell, Andrew Hayen, Petra Macaskill, et al.
Stroke|September 10, 2005
Associations of inflammatory and hemostatic variables with the risk of recurrent strokeMark Woodward, Gordon D O Lowe, Duncan J Campbell, et al.
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.
Pageof 102